170 related articles for article (PubMed ID: 32271809)
1. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
[TBL] [Abstract][Full Text] [Related]
3. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
5. Potential of MALDI-TOF-based serum N-glycan analysis for the diagnosis and surveillance of breast cancer.
Lee JW; Lee K; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Choi S; Chang S; Ko CK; Lee SB; Kim DC
Sci Rep; 2020 Nov; 10(1):19136. PubMed ID: 33154535
[TBL] [Abstract][Full Text] [Related]
6. Differential
Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
[TBL] [Abstract][Full Text] [Related]
7. A serum glycomics approach to breast cancer biomarkers.
Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted deglycosylation for rapid and sensitive analysis of N-glycans via glycosylamine derivatization.
Wu Y; Wang C; Luo J; Liu Y; Zhang L; Xia Y; Feng X; Liu BF; Lin Y; Liu X
Anal Bioanal Chem; 2017 Jun; 409(16):4027-4036. PubMed ID: 28417175
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.
Tang Z; Varghese RS; Bekesova S; Loffredo CA; Hamid MA; Kyselova Z; Mechref Y; Novotny MV; Goldman R; Ressom HW
J Proteome Res; 2010 Jan; 9(1):104-12. PubMed ID: 19764807
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric screening of ovarian cancer with serum glycans.
Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
13. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
[TBL] [Abstract][Full Text] [Related]
14. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
15. Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.
Mitra I; Alley WR; Goetz JA; Vasseur JA; Novotny MV; Jacobson SC
J Proteome Res; 2013 Oct; 12(10):4490-6. PubMed ID: 23984816
[TBL] [Abstract][Full Text] [Related]
16. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
18. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.
Ressom HW; Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R
J Proteome Res; 2008 Feb; 7(2):603-10. PubMed ID: 18189345
[TBL] [Abstract][Full Text] [Related]
19. [Application of serum proteomic mass spectrum analysis in breast cancer].
Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
[TBL] [Abstract][Full Text] [Related]
20. Serum N-glycan profiles differ for various breast cancer subtypes.
Vreeker GCM; Vangangelt KMH; Bladergroen MR; Nicolardi S; Mesker WE; Wuhrer M; van der Burgt YEM; Tollenaar RAEM
Glycoconj J; 2021 Jun; 38(3):387-395. PubMed ID: 33877489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]